Pharmacological Interventions Behavioural and Depression: 42% - - PowerPoint PPT Presentation

pharmacological interventions behavioural and
SMART_READER_LITE
LIVE PREVIEW

Pharmacological Interventions Behavioural and Depression: 42% - - PowerPoint PPT Presentation

Pharmacological Interventions Behavioural and Depression: 42% Psychological Agitation: 35% Anxiety: 35% Irritability: 30% Delusions: 22% Symptoms of Aberrant motor behaviour: 25% Sleep Disturbance: 14% Disinhibition: 12% Hallucinations:


slide-1
SLIDE 1

Pharmacological Interventions

slide-2
SLIDE 2
slide-3
SLIDE 3

Behavioural and Psychological Symptoms of Dementia – 90%

Depression: 42% Anxiety: 35% Delusions: 22% Sleep Disturbance: 14% Hallucinations: 8.5% Agitation: 35% Irritability: 30% Aberrant motor behaviour: 25% Disinhibition: 12%

slide-4
SLIDE 4

50% of people living with dementia

PAIN

Higher prevalence than in cancer at end of life

slide-5
SLIDE 5

THINK DELIRIUM

slide-6
SLIDE 6

Cognitive symptoms of dementia: 100%

slide-7
SLIDE 7
slide-8
SLIDE 8
slide-9
SLIDE 9
slide-10
SLIDE 10

Golden rules

  • 1. Speak to family.
  • 2. What does the patient with dementia want?
  • 3. Advanced decisions.
  • 4. Advanced statements.
  • 5. Legal framework for drug administration.
  • 6. Low and slow.
  • 7. Titrate to effect.
  • 8. Consider all side effects / contraindications.
  • 9. Speak to family.
slide-11
SLIDE 11
slide-12
SLIDE 12

Nociceptive pain

  • Regular paracetamol.
  • Remove stimulus – Think constipation,

GORD, wind.

  • NSAIDS + PPI.
  • Opiates.
slide-13
SLIDE 13

Neuropathic pain

  • SNRI
  • Amitriptyline
  • Pregabalin
slide-14
SLIDE 14

Golden rules

1. Speak to family. 2. What does the patient with dementia want? 3. Advanced decisions. 4. Advanced statements. 5. Legal framework for drug administration.

  • 6. Low and slow.
  • 7. Titrate to effect.
  • 8. Consider all side effects / contraindications.

9.Speak to family.

slide-15
SLIDE 15
  • SSRI – Sertraline, Fluoxetine, Citalopram.
  • Mirtazapine – positive side effect profile.
  • Trazadone – agitation, hypnotic.
  • Venlafaxine / Duloxetine.
slide-16
SLIDE 16
slide-17
SLIDE 17

Pregabalin* Mirtazapine Selective serotonin reuptake inhibitor

slide-18
SLIDE 18

Antipsychotics

  • When and what to prescribe…..
  • Treat the symptom not the

behviour

slide-19
SLIDE 19

Antipsychotics

  • Risperidone - ? The safe (er) option?
  • Olanzapine – The all rounder.
  • Aripiprazole – Cardiologists friend
  • Amisulpride – Diabetologists friend
  • Haloperidol – The junior doctors friend
  • Quetiapine – Neurologists friend
slide-20
SLIDE 20

IM antipsychotics

  • Convenience vs drug
  • Rule 2
  • Legal framework
slide-21
SLIDE 21

Golden rules

1. Speak to family. 2. What does the patient with dementia want? 3. Advanced decisions. 4. Advanced statements.

  • 5. Legal framework for drug administration.

6. Low and slow. 7. Titrate to effect.

  • 8. Consider all side effects / contraindications.
  • 9. Speak to family.
slide-22
SLIDE 22
slide-23
SLIDE 23
  • Can dopaminergic medication be reduced?
  • Rivastigmine
  • Quetiapine
  • ?Clozapine?

Psychotic symptoms in Parkinson’s disease

slide-24
SLIDE 24

Sleep / wake reversal

slide-25
SLIDE 25

Sleep wake cycle

  • Melatonin 10mg– mixed evidence,

cochrane, no effect and low side effects.

  • Trazadone 50mg-100mg – improved time to

sleep and time asleep

  • Ramelteon 8mg – no effects and poor

evidence base.

slide-26
SLIDE 26
  • Acetylcholinesterase

inhibitors*

  • Memantine*
  • Trazadone
slide-27
SLIDE 27
slide-28
SLIDE 28
slide-29
SLIDE 29

georgecrowther@nhs.net